Needham Capital Partners Overview
- Investor Type
-
Growth/Expansion
- Status
-
Inactive
- Investments
-
76
- Exits
-
59
Needham Capital Partners General Information
Description
Needham Capital Partners was a private equity firm that managed funds which invested primarily in the equities of private growth companies. The firm focused entirely on long-term capital appreciation. The firm invested in the United States based companies.
Contact Information
Website
www.needhamcapital.com
Investor Status
Out of Business
Trade Association
National Venture Capital Association (NVCA)
Primary Investor Type
Growth/Expansion
Other Investor Types
Asset Manager
Hedge Fund
PE/Buyout
Venture Capital
Primary Office
- 250 Park Avenue
- New York, NY 10177
- United States
Needham Capital Partners Investments (76)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| 0000000000 | 09-Feb-2012 | 00000 00000 | 0000 | Application Software | Generating Revenue | |
| 0000000 | 14-Feb-2011 | 00000000000 | 00.00 | Laboratory Services (Healthcare) | Generating Revenue/Not Profitable | |
| 0000000000 | 13-Mar-2009 | 00000 00000 | 000 | Application Software | Generating Revenue | |
| 00000000000 | 09-Oct-2008 | 00000 00000 | 000 | Electronics (B2C) | Generating Revenue | |
| ChipX | 23-Jul-2008 | Later Stage VC | 000 | General Purpose Semiconductors | Generating Revenue |
Needham Capital Partners Exits (59)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| 000000000000 | 19-Nov-2021 | 000000000 00000000 | 00000 |
| 0000000 | 19-Nov-2021 | 000000 0000000000 | 00000 |
| 00000000 0000000 | 25-Feb-2019 | 000000000 00000000 | |
| 000 000000000000 | 01-Jul-2018 | 000000000000000000 | |
| Kanisa Pharmaceuticals | 01-Jan-2018 | Bankruptcy: Liquidation |
Needham Capital Partners Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
